| Symbol | CMPS |
|---|---|
| Name | COMPASS PATHWAYS PLC |
| Sector | HEALTH CARE |
| Region | Europe |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 33 BROADWICK STREET,3RD FLOOR, LONDON, W1F 0DQ, United Kingdom |
| Telephone | 1-716-676-6461 |
| Fax | — |
| — | |
| Website | https://compasspathways.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001816590 |
| Description | Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360. Additional info from NASDAQ: |
Compass Pathways - Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioners National Priority Voucher
Read moreCompass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioners National Priority Voucher
Read moreCompass Pathways - Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments
Read moreCompass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments
Read moreCompass Pathways - Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026
Read moreCompass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026
Read moreCompass Pathways - Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments
Read moreCompass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments
Read moreNew Form ARS - COMPASS Pathways plc <b>Filed:</b> 2026-04-15 <b>AccNo:</b> 0001193125-26-157141 <b>Size:</b> 9 MB
Read moreNew Form DEF 14A - COMPASS Pathways plc <b>Filed:</b> 2026-04-15 <b>AccNo:</b> 0001193125-26-157123 <b>Size:</b> 3 MB
Read more